Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.

Prothena Corporation plc is a late-stage clinical company with expertise in protein dysregulation and a pipeline of novel investigational therapeutics with the potential to change the course of devastating rare peripheral amyloid and neurodegenerative diseases. Fueled by its deep scientific expertise built over decades of research, Prothena is advancing a pipeline of therapeutic candidates for a number of indications and novel targets for which its ability to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be leveraged. Prothena‚Äôs pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer‚Äôs disease, Parkinson‚Äôs disease and a number of other neurodegenerative diseases.

Prothena

Medical Director

Medical Director, Vaccine Development

Mindoula is a next generation population health management company that scales the human connection through technology.

Mindoula is a next generation population health management company that scales the human connection through technology in addressing mind, body, and life challenges. We identify, engage, and serve populations with behavioral health and medical challenges across the continuum of care. Our adaptive data science approach, multi-platform technology stack, and virtual + in-person care extension teams enable our payer and provider partners to achieve improved outcomes and significantly reduced costs by integrating behavioral, medical, and social determinants of health.

Mindoula Health

Maryland Inpatient BHU Medical Director - Adult Psych Unit

Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.

Kite Pharma is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient's own immune system to fight tumor cells. These potential therapies could provide novel strategies for the treatment and management of a wide range of tumor types.

Kite Pharma

Medical Director, Clinical Development

Journey Clinical is a platform that provides services to member psychotherapy practices which are independently owned and operated.

Journey Clinical is a platform that provides services to member psychotherapy practices that are independently owned and operated, and in no way owns, directs, or controls the mental healthcare clinicians providing care.

Journey Clinical

Journey Clinical is seeking a Georgia ( GA ) Medical Director

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.

ImmPACT Bio

FogPharma is a biopharmaceutical firm that develops precision medicines for the vast majority of therapeutic targets.

FogPharma was born from the scientific and entrepreneurial vision of founder Greg Verdine, a pioneer in the discovery and development of new drug classes that ‚Äúdrug the undruggable.‚Äù FogPharma‚Äôs cell-penetrating mini proteins (CPMPs) are a broad new class of medicines that can drug targets beyond the reach of conventional therapeutics. Together with world-leading experts and collaborators in cancer biology and therapy, our team is building a drug discovery powerhouse having passion, knowledge, and creativity to develop fundamentally new cancer treatments. FogPharma derives financial support from a unique syndicate of extraordinary private and institutional investors. FogPharma‚Äôs network of friends includes our founders, employees, investors, advisors, collaborators, and cancer patients; all working together to pioneer a unique approach toward conquering cancer. It is laser-focused and unstoppable in its mission to deliver a new class of medicines to patients and their families to bring them years to life and life to years.

FogPharma

Medical Director / Senior Medical Director, Clinical Development

Deep Lens focuses on enabling faster recruitment of cancer patients for clinical trials at the time of diagnosis.

Deep Lens is a provider of a digital pathology workflow platform intended to allow pathology groups to collaborate on groundbreaking cancer research. The company's platform includes AI-powered image detection and workflow support, collaboration, cloud storage, and built-in APIs for the ingestion of third-party AI models and integration to EMR, LIMS, and other systems, helping patients, pathologists, and physicians work together to accelerate and optimize treatment. Founded in 2017, Deep Lens is headquartered in Columbus, Ohio.

Deep Lens

CorroHealth helps individuals in the reimbursement and revenue cycle with risk-based programs to improve financial healthcare returns.

Location

Company Stage

Age of Data

Experience

Industry

Company